|
|
Recent Articles
-
Taiwan Semi Puts Up Strong First Quarter, Gives Cautious Outlook
Apr 18, 2024
-
Image: Taiwan Semiconductor’s shares have rallied considerably since the October 2022 bottom.
Taiwan Semiconductor put up decent first quarter 2024 results, and its outlook for the second quarter of the year was healthy, albeit not as strong as some investors might have liked. We like its pure-play foundry business, and while there was some cautious commentary on the conference call, we’re sticking with Taiwan Semiconductor as an idea in the ESG Newsletter portfolio.
-
ASML Reports First Quarter Results, Reiterates Guidance
Apr 17, 2024
-
Image: ASML Holding is one of our favorite semiconductor ideas.
On April 17, ASML Holding reported decent first quarter 2024 results. First quarter net sales came in at €5.29 billion on a gross margin of 51.0%. Net income was €1.22 billion in the quarter. Net bookings in the first quarter of 2024 came in at €3.6 billion, down sequentially from the strong net bookings number delivered in the fourth quarter of 2023. The company continues to be shareholder friendly, paying dividends and buying back €400 million worth of stock during the first quarter. Though management expects 2024 total net sales to be similar to 2023, we like how ASML is positioned for the long run.
-
Johnson & Johnson Narrows 2024 Outlook, Raises Dividend
Apr 16, 2024
-
Image Source: J&J.
Looking to 2024, J&J expects adjusted operational sales growth in the range of 5.5%-6%, the midpoint of which is up from the prior range of 5%-6%. Adjusted operational diluted earnings per share is targeted in the range of $10.60-$10.75 per share, the midpoint also up from the range of $10.55-$10.75 previously. Management also upped its dividend 4.2%, to a quarterly payout of $1.24 per share, implying a forward estimated dividend yield of 3.4%. We like J&J, but we won’t be adding it back to any newsletter portfolio anytime soon.
-
UnitedHealth Group Reiterates 2024 Adjusted Net Earnings Outlook
Apr 16, 2024
-
Image: UnitedHealth Group’s shares have been choppy during the past couple years.
UnitedHealth Group’s shares have seen better days as the firm works to recover from a cyberattack, while the industry’s medical costs are on the rise as patients begin to pursue procedures that were deferred during the peak of the COVID-19 crisis. Though it may be some time for UnitedHealth Group’s performance to normalize given the cyberattack and pent-up demand, we liked that it maintained its adjusted net earnings outlook for 2024 amid concerns of rising costs. UnitedHealth remains a key idea in the Best Ideas Newsletter portfolio.
|
